trending Market Intelligence /marketintelligence/en/news-insights/trending/N9lms0nZ59bAqr_MEbTIfg2 content esgSubNav
In This List

Ultragenyx appoints independent director

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises

Blog

Essential IR Insights Newsletter - Summer July-August 2023

Blog

Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits


Ultragenyx appoints independent director

Ultragenyx Pharmaceutical Inc. appointed Deborah Dunsire to the company's board of directors.

Dunsire, currently president and CEO of XTuit Pharmaceuticals Inc., will serve as an independent director on Ultragenyx's board.